GABRG2 rs17070145: Understanding Your Genetic Variant
The rs17070145 variant is a genetic change located within the GABRG2 gene, which provides instructions for building a key component of the brain's inhibitory signaling system. This variant is studied for its potential role in influencing susceptibility to various epilepsy phenotypes by affecting how neurons communicate.
What each genotype means
Typical GABRG2 variant profile
This genotype represents the common variant state for this location in the GABRG2 gene. While GABRG2 is known to harbor rare pathogenic mutations linked to epilepsy syndromes, this specific common genotype is generally considered part of the normal genetic variation observed in the population.
This genotype is widely distributed and found in the majority of individuals across most global populations.
Typical GABRG2 variant profile
This genotype represents the common variant state for this location in the GABRG2 gene. While GABRG2 is known to harbor rare pathogenic mutations linked to epilepsy syndromes, this specific common genotype is generally considered part of the normal genetic variation observed in the population.
This genotype is widely distributed and found in a significant portion of individuals across most global populations.
Typical GABRG2 variant profile
This genotype represents the common variant state for this location in the GABRG2 gene. While GABRG2 is known to harbor rare pathogenic mutations linked to epilepsy syndromes, this specific common genotype is generally considered part of the normal genetic variation observed in the population.
This genotype is widely distributed and found in the majority of individuals across most global populations.
What is the rs17070145 Variant?
The rs17070145 variant is a single nucleotide polymorphism (SNP) located within the GABRG2 gene on chromosome 5. In genetics, a SNP represents a variation at a single position in the DNA sequence among individuals. This specific variant is categorized as a common genetic marker, meaning it appears frequently across diverse human populations. Because it sits within the GABRG2 gene, researchers investigate whether this specific change in the DNA code alters the structure or expression of the protein it encodes. While many SNPs have no observable effect on health, those located in functional genes are often prioritized in research to determine if they contribute to biological differences or disease susceptibility. Understanding the location of this variant helps scientists map how specific genetic regions influence neurological health.
The Role of the GABRG2 Gene
The GABRG2 gene encodes the gamma-2 subunit of the GABA-A receptor. GABA is the primary inhibitory neurotransmitter in the mammalian brain, acting like a 'brake' to prevent over-excitation of neurons. GABA-A receptors are complex, pentameric structures that function as ligand-gated chloride channels. When GABA binds to these receptors, they open to allow chloride ions into the cell, which stabilizes the neuron and reduces its likelihood of firing. The gamma-2 subunit is essential for the proper assembly, trafficking, and function of these receptors, as well as for their sensitivity to benzodiazepines. Because this system is critical for maintaining the balance between excitation and inhibition in the brain, any dysfunction in the GABRG2 gene can disrupt this delicate equilibrium, potentially leading to increased neuronal excitability.
Research and Evidence Strength
Research into GABRG2 has established a clear link between rare, pathogenic mutations in this gene and a spectrum of epilepsy syndromes, including childhood absence epilepsy, febrile seizures, and Dravet syndrome. However, the evidence for common variants like rs17070145 is more nuanced. While the gene itself is strongly implicated in epilepsy, the specific association of rs17070145 with clinical outcomes is considered to have moderate evidence strength. Statistical associations observed in large-scale studies suggest that this variant may contribute to susceptibility, but it is rarely the sole cause of a condition. In complex traits like epilepsy, genetic risk is often polygenic, meaning it results from the combined effect of many variants rather than a single SNP. Consequently, the presence of this variant does not guarantee the development of any condition, and its clinical significance remains a subject of ongoing investigation.
What You Can Do With This Information
Genetic information regarding variants like rs17070145 is intended for educational purposes and should not be used for self-diagnosis or medical decision-making. If you have concerns about your health or a family history of neurological conditions, the most appropriate step is to consult with a qualified healthcare professional, such as a neurologist or a genetic counselor. They can provide context based on your personal medical history and clinical symptoms. It is important to remember that genetic variants are only one piece of a much larger puzzle that includes environmental factors and other genetic influences. Never make changes to medications or treatment plans based on genetic test results without first discussing them with your clinician or pharmacist, as they are best equipped to interpret these findings in the context of your overall health.
How common is this variant?
The rs17070145 variant is considered a common SNP, with its alleles appearing at varying frequencies across global populations. Specific frequency data can be accessed through large-scale genomic databases like gnomAD.
Frequently asked questions
Does having the rs17070145 variant mean I have epilepsy?
No. Having this variant does not mean you have or will develop epilepsy. Many people carry common genetic variants without ever experiencing neurological symptoms, as epilepsy is a complex condition influenced by many factors.
Is GABRG2 related to medication response?
The GABRG2 gene is involved in the function of GABA-A receptors, which are targets for certain medications like benzodiazepines. If you are concerned about how your genetics might affect your response to medication, please discuss this with your doctor or pharmacist.
Where can I find more information about GABRG2?
You can find reliable information about the GABRG2 gene and its associated conditions through resources like MedlinePlus Genetics, the NCBI Gene database, and peer-reviewed research articles on PubMed.
Should I get tested for this variant?
Genetic testing for specific SNPs is generally not recommended unless there is a clear clinical indication. If you have concerns about your health, consult a healthcare provider who can determine if genetic testing is appropriate for your situation.
Sources & further reading
Educational information only, last refreshed 9/20/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs17070145?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in GABRG2
This variant in the GABRG2 gene is associated with variations in response to certain anticonvulsant medications and epilepsy susceptibility.
Variant in GABRG2, a gene where mutations can alter GABA-A receptor function and influence seizure thresholds.
Mutations in GABRG2 are linked to a spectrum of epilepsy ranging from simple febrile seizures to severe developmental and epileptic encephalopathies.
This variant is located in the GABRG2 gene, which encodes the gamma-2 subunit of the GABA-A receptor; variants in this gene are associated with a spectrum of epilepsy syndromes.
A common variant in GABRG2, a gene encoding a GABA-A receptor subunit linked to various epilepsy phenotypes including febrile seizures and GEFS+.
Linked to GABA-A receptor subunit dysfunction, a known mechanism for inherited epilepsy syndromes.